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Synapsins are a family of neuron-specific phosphoproteins that regulate neurotransmitter release by associating with synaptic vesicles.
Synapsins consist of a series of conserved and variable structural domains of unknown function. We performed a systematic structure–
function analysis of the various domains of synapsin by assessing the actions of synapsin fragments on neurotransmitter release,
presynaptic ultrastructure, and the biochemical interactions of synapsin. Injecting a peptide derived fromdomain A into the squid giant
presynaptic terminal inhibited neurotransmitter release in a phosphorylation-dependent manner. This peptide had no effect on vesicle
pool size, synaptic depression, or transmitter release kinetics. In contrast, a peptide fragment from domain C reduced the number of
synaptic vesicles in the periphery of the active zone and increased the rate and extent of synaptic depression. This peptide also slowed the
kinetics of neurotransmitter release without affecting the number of docked vesicles. The domain C peptide, as well as another peptide
fromdomainE that is known tohave identical effects on vesicle pool size and release kinetics, both specifically interferedwith thebinding
of synapsins to actin but not with the binding of synapsins to synaptic vesicles. This suggests that both peptides interfere with release by
preventing interactions of synapsinswith actin. Thus, interactions of domains C andEwith the actin cytoskeletonmay allow synapsins to
perform two roles in regulating release, whereas domain A has an actin-independent function that regulates transmitter release in a
phosphorylation-sensitive manner.
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Introduction
Synapsins are a family of presynaptic phosphoproteins that asso-
ciate with synaptic vesicles (SVs) (Huttner et al., 1983; DeCamilli
et al., 1990;Greengard et al., 1993;Hilfiker et al., 1999). Synapsins
are expressed in vertebrate and invertebrate nervous systems,
with a single gene found in invertebrates (Klagges et al., 1996;
Hilfiker et al., 1998; Kao et al., 1999; Humeau et al., 2001) and
three genes (synapsins I, II, and III) found in mammals (De Ca-
milli et al., 1990; Hosaka and Su¨dhof, 1998b; Kao et al., 1998).
The primary structure of synapsins consists of multiple common
and unique regions (Su¨dhof et al., 1989; Kao et al., 1999). These
are thought to represent functional domains, although their spe-
cific functions are not yet clear.
Several lines of evidence indicate that synapsins regulate the
supply of synaptic vesicles available for exocytosis. Perturbation
of synapsin function in a variety of experimental systems in-
creases synaptic depression, indicating that synapsins are re-
quired to sustain neurotransmitter release during high levels of
neuronal activity (Li et al., 1995; Pieribone et al., 1995; Rosahl et
al., 1995; Takei et al., 1995; Hilfiker et al., 1998; Chi et al., 2001;
Humeau et al., 2001; Gitler et al., 2004b). These perturbations
also decrease the number of vesicles in the periphery of the active
zone, suggesting that synapsins participate in transmitter release
by regulating a reserve pool of synaptic vesicles. Synapsins have
also been implicated in other forms of short-term plasticity, such
as posttetanic potentiation (Rosahl et al., 1993, 1995; Humeau et
al., 2001), and in modulating a post-docking step of the release
process (Hilfiker et al., 1998; Humeau et al., 2001).
In vitro, synapsins exhibit a number of biochemical activities.
They bind, in a phosphorylation-dependentmanner, to lipid and
protein components of synaptic vesicles (Schiebler et al., 1986;
Benfenati et al., 1989a,b). This may allow synapsins to associate
with synaptic vesicles. Synapsins also bind to various cytoskeletal
proteins, including actin, spectrin, andmicrotubules (Baines and
Bennett, 1985, 1986; Ba¨hler and Greengard, 1987; Petrucci and
Morrow, 1987; Benfenati et al., 1992a; Hurley et al., 2004). These
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propertiesmayallowsynapsins tokeepvesicles in the reservepool by
reversibly cross-linking vesicles to each other and/or to the presyn-
aptic cytoskeleton. In addition, synapsins bind ATP (Hosaka and
Su¨dhof, 1998a) and are structurally similar to a group of ATP-using
enzymes (Esser et al., 1998; Brautigam et al., 2004), suggesting that
synapsins may have an enzymatic function.
In this paper, we correlated the structural, physiological, and
biochemical properties of synapsins by defining the functions of
individual domains of synapsins. Our data support the idea that
synapsins are multifunctional proteins and that individual do-
mains confer specific functions to synapsins. Domains C and E
regulate the availability of synaptic vesicles for release by binding
to a presynaptic actin scaffold and thereby maintaining a vesicle
pool in the periphery of the plasma membrane, whereas domain
A has a different function that regulates neurotransmitter release
in a phosphorylation-dependent manner.
Materials andMethods
Peptides. Peptides were synthesized either by the Keck Foundation Bio-
technology Resource Laboratory at Yale University (NewHaven, CT), by
the Rockefeller University Protein/DNA Technology Center (New York,
NY), or by Research Genetics/Invitrogen (Huntsville, AL). In all cases,
peptides were purified (95% pure) by reversed-phase HPLC, and their
identitywas confirmedbymass spectroscopy. Peptideswere resuspended
in peptide injection buffer (in mM: 200 KCl, 100 taurine, 200
K-isethionate, and 50 K-HEPES, pH 7.4) that was designed to mimic
squid axoplasm while maintaining proper secondary structure of the
peptides. The final concentration of peptide in the injection solution
ranged from 2 to 40 mM; if necessary, the pH was adjusted to 7.4. All
peptides were subjected to sequence similarity searches using the Na-
tional Center for Biotechnology Information BLAST (basic local align-
ment search tool) program (www.ncbi.nlm.nih.gov) to ensure that
the peptides had no significant homology with the sequences of
other proteins. In addition, secondary structure predictions (http:
//www.predictprotein.org) were performed for all peptides. In cases in
which a prediction indicated a high probability for a given peptide to
form a distinct secondary structure, control scrambled peptides were
designed to retain this feature of predicted secondary structure.
Physiological measurements. Electrical measurements and microinjec-
tions were performed on isolated stellate ganglia of Loligo pealei, as de-
scribed previously (Bommert et al., 1993; Hilfiker et al., 1998). In brief,
ganglia were superfused with oxygenated physiological saline (10–15°C)
containing the following (inmM): 466NaCl, 54MgCl2, 11 CaCl2, 10 KCl,
3 NaHCO3, and 10 HEPES, pH 7.2. Electrodes filled with 3 M KCl were
inserted into the presynaptic and postsynaptic axons. Unless otherwise
noted, action potentials were evoked every 30 s (0.033 Hz) by depolariz-
ing the presynaptic axon with a current pulse (0.7–1.9 mA, 0.5 ms dura-
tion). Transmitter release was measured by recording EPSPs elicited by
presynaptic action potentials and measuring the rate of rise of the EPSPs
at a time point before the responses reached action potential threshold. A
third microelectrode was used to microinject reagents and record the
presynaptic action potential. The microinjection electrode was con-
nected to a Picospritzer injector (General Valve, Fairfield, NJ) that ap-
plied pulses of positive pressure (10–90 ms; 10–100 psi; N2 gas) and
contained peptides dissolved to the indicated concentrations in peptide
injection buffer. Fluorescein dextran (polymer size of 3 kDa, 0.1 mM;
Molecular Probes, Eugene,OR)was coinjected to estimate the amount of
peptide that had been injected. The resulting fluorescence was imaged
with a Zeiss (Oberkochen, Germany) Axioskop microscope (10 mag-
nification) and detected with a Cohu (San Diego, CA) silicon-intensified
target camera. Depression was elicited by a train of stimuli (5 s, 50 Hz),
and the time course of depression was estimated from double-
exponential fits to the time-dependent decay of EPSP slopes during the
train. The time constants () shown are those of the faster and larger
exponential term. Synaptic depression was measured while lowering ex-
ternal calcium concentration from 11 to 2.2–3.7 mM. For voltage-clamp
recordings, the current-passing and voltage-measuring electrodes con-
tained 7 MCsCl and 3 MKCl, respectively (Augustine et al., 1985). Signals
were recorded with an Axoclamp-2A amplifier (Axon Instruments,
Union City, CA). Data were filtered at 3–10 kHz, digitized at 33 kHz, and
analyzed using software written in Axobasic (Axon Instruments).
Electron microscopy. Fixation and processing of squid tissue was con-
ducted as described previously (Sanchez et al., 1990). Briefly, peptides
were microinjected, and their physiological effects were simultaneously
monitored by eliciting presynaptic action potentials every 30 s. Termi-
nals injected with control (scrambled) or active peptides (inhibition of
transmitter release 85%) were fixed and processed together. For each
condition, two terminals were analyzed, and the data were pooled. All
terminals were sectioned, at 75 m intervals, along their length, and
sections were examined with a JEM-1200 ExII (Joel, Peabody, MA) elec-
tron microscope. Images of all active zones encountered were digitized
and analyzed using Image-1 software (Universal Imaging Corporation,
Philadelphia, PA). Because active zones typically are spaced 1 m
apart, only synaptic vesicles within 500 nm of the active zone were mea-
sured to ensure that vesicles were only counted once. Morphometric
analyses were done blind to condition, with experimental and control
micrographs analyzed in intermixed groups of unknown treatment.
Phosphorylation assays. Synapsin I was purified from bovine brain as
described previously (Schiebler et al., 1986; Ba¨hler and Greengard, 1987)
and used as a control to test the activity of all kinases studied. The cata-
lytic subunit of protein kinase A (PKA)was purified frombovine heart as
described previously (Kaczmarek et al., 1980). Recombinant calcium/
calmodulin-dependent protein kinase I (CaMKI) was expressed in bac-
teria and purified as described previously (Picciotto et al., 1993). Peptide
phosphorylation assays were performed as described previously (Hem-
mings et al., 1989; Picciotto et al., 1992).
For kinetic analyses, phosphorylation assays were performed with
peptide concentrations that varied from2 to 500M. The total amount of
PKA catalytic subunit and CaMKI per reaction was 50 and 25 ng, respec-
tively. The incorporation of 32P was linear with these concentrations of
peptides and kinases. The Km and kcat values were calculated from linear
regression analysis of Lineweaver-Burk transformations (1/cpm vs
1/[peptide]), describing the initial rates of phosphorylation as a function
of substrate concentration. Data represent means of eight (for PKA) or
four (for CaMKI) independent experiments, done in duplicate. The ef-
fects of switched squid domain A peptide (switched s-pepA) (10–500M
final concentration) or of PKI-amide (Walsh inhibitor peptide) [TTY-
ADFIASGRTGRRNAIHD (Walsh et al., 1971; Walsh and Glass, 1991); 5
nM to 50M final concentration] on the phosphorylation of s-pepAwere
assessed under initial rate conditions as described above, and experi-
ments were repeated three times in duplicate.
Synaptic vesicle binding assays. Subcellular fractionation of rat fore-
brain from homogenate to highly purified SVs was performed through
the step of controlled-pore glass chromatography as described previously
(Huttner et al., 1983). Purified synaptic vesicles containing endogenous
synapsins (untreated SVs) were quantitatively depleted of synapsin I by
exposure to mild salt treatment (synapsin-depleted SVs) and reassoci-
ated in vitro with purified synapsin I (rebound SVs) as described previ-
ously (Schiebler et al., 1986). The complete removal of endogenous syn-
apsins from SVs during salt treatment (Huttner et al., 1983) was
routinely verified by immunoblotting. The binding of synapsin I to
synapsin-depleted SVs was measured using a high-speed sedimentation
assay (Benfenati et al., 1989b). The recovery of SVs, used to correct the
amounts of bound synapsin I, was determined by immunoblotting of
parallel samples using anti-synaptophysin antibodies. Nonspecific bind-
ing was determined asmeasured by the amount of synapsin I in the pellet
in the absence of synaptic vesicles.
Actin binding, bundling, and polymerization assays. Globular actin (G-
actin) (5 M), purified as described previously (Benfenati et al., 1992a),
was polymerized for 1 h at room temperature by the addition of 90 mM
KCl/1 mM MgCl2 and incubated at 25°C for 1 h with or without 0.5 M
synapsin I, and in the presence or absence of either pepA, pepC5, pepE or
scrambled versions thereof (0.1–5 mM). Identical samples were centri-
fuged either at low speed (10,000  g for 10 min) for recovery of actin
bundles or subjected to high-speed centrifugation in a Beckman Instru-
ments (Fullerton, CA) TLA-100 rotor (400,000  g for 30 min) for
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recovery of total filamentous actin (F-actin) (Ba¨hler and Greengard,
1987). The actin pellets and supernatant fractions were solubilized in
Laemmli’s sample buffer and subjected to SDS-PAGE (Laemmli, 1970).
The amounts of actin in the various fractions were detected by Coomas-
sie blue staining, whereas the amounts of synapsin I bound to actin, or
free in the supernatant, were determined by either protein staining of the
gels or immunoblotting. The relationship between peptide concentra-
tion and degree of inhibition of the interaction of synapsin with F-actin
by various peptides was determined by quantifying the amounts of pel-
leted synapsin I by normalizing relative to the amounts of pelleted
F-actin. Quantitative analysis of Coomassie blue-stained gels or immu-
noblots was performed by laser scanning densitometry (Ultroscan XL;
LKB-Produkter, Bromma, Sweden) by interpolation of the density values
into a suitable standard curve.
The polymerization of actin in the absence of K/Mg2 was moni-
tored by recording the enhancement of pyrenyl-actin fluorescence in a
PerkinElmer (Wellesley, MA) LS50 spectrophotometer as described pre-
viously (Fesce et al., 1992; Valtorta et al., 1992).
Results
Identification of functional domains of synapsins
To identify functionally important regions of synapsins, we de-
signed a series of peptides covering almost the entire sequence
of squid synapsins (supplemental Fig. 1, available at www.
jneurosci.org as supplementalmaterial).When the homology be-
tween squid and rat synapsins was high, we also used previously
synthesized peptides derived from the sequences of rat synapsins.
Some of the peptides derived from hydrophobic regions within
the central, conserved domain C of synapsins were insoluble in
injection buffer and could not be considered further. The re-
maining peptides were dissolved in injection buffer at the highest
possible concentration and thenmicroinjected into the giant pre-
synaptic terminal of squid. The amount of peptide injected varied
from experiment to experiment, depending on the ability of the
microinjection pipette to deliver peptide. For each peptide, we
determined the mean degree of inhibition produced, across all
experiments, whether or not saturating concentrations of peptide
were injected. This parameter provides ameans of distinguishing
active from inactive peptides and is indicated as Amplitude inhi-
bition in Table 1. In addition, for those peptides that were found
to be active, we further determined whether a saturating concen-
tration of peptide was able to completely inhibit synaptic trans-
mission (Table 1, Full inhibition).
Several peptides were found to have dramatic effects on neu-
rotransmitter release. A peptide derived from the evolutionarily
conserved domainAof squid synapsins caused a pronounced and
reversible reduction in the amplitude and rate of rise of EPSPs
evoked by presynaptic action potentials (Fig. 1A). In the example
shown in Figure 1A, the inhibition of transmitter release induced
by this peptide, termed s-pepA, was sufficient to reduce EPSPs
below the threshold for evoking an action potential (middle).
Synaptic transmission could be completely abolished by injection
of a sufficient amount of s-pepA, and the inhibition of transmis-
sion was reversed after ceasing peptide injection (Fig. 1A, right,
B). This recovery presumably was attributable to diffusion of the
peptide out of the presynaptic terminal and into the adjacent
presynaptic axon. This indicates that the inhibition was attribut-
able to the action of the peptide rather than the injection proce-
dure per se. A scrambled control peptide (scrambled s-pepA),
possessing an amino acid composition identical to that of s-pepA
and similar predicted secondary structure but with a randomized
primary sequence, had no effect on transmitter release (Fig. 1C,
Table 2). This indicates that the inhibition of transmitter release
Table 1. Effects of synapsin peptides on synaptic transmission
Peptide
Concentration
(mM)
Number of
injections
Amplitude
inhibition (%)
Full inhibition
(95%)
s-pepA 20 10 75 6 Yes
s-pepB 20 3 14 11 No
rl-pepC1 n.s.
s-CaM1 10 3 83 13 Yes
rl-pepC3 n.s.
rl-pepC4 3 4 0 No
rl-pepC5 n.s.
rl-pepC11 n.s.
s-pepC1 20 4 13 1 No
s-pepC2 10 6 33 13 No
s-TID3N 10 7 19 2 n.a.
s-pepC3 n.s.
s-pepC4 n.s.
s-CaM2 10 3 75 11 No
s-pepC5 10 14 80 5 Yes
rl-pepC12 n.s.
s-pepC6 n.s.
rl-pepC13 3 3 0 No
s-pepV1 40 3 0 No
s-pepV2 20 3 0 No
s-pepV3 20 1 0 No
Short s-pepE 2 5 80 6 Yes
Peptides correspond to the sequences indicated in Figure 1. They were dissolved to the indicated concentrations in
peptide injection buffer. n.s., Not soluble; n.a., not applicable. EPSPs were measured before and at the peak of
inhibition of the indicated peptides. Data are means SEM. Peptides were scored as being able to fully inhibit
neurotransmitter release if they could decrease EPSPs by95% in at least two individual experiments. s-, Peptides
derived from squid synapsin sequences; rl-, peptides derived from rat synapsin I sequences.
Figure 1. s-pepA and s-pepC5 inhibit neurotransmitter release. A, Examples of presynaptic
andpostsynaptic potentials recordedbefore (Control), during (s-pepA), and1hafter (Recovery)
injection of s-pepA.B, Injection of s-pepA (solid bar) reversibly inhibited transmitter release. C,
Scrambled s-pepA had no effect on transmission. D, Injection of s-pepC5 (solid bar) reversibly
inhibited neurotransmitter release. E, Scrambled s-pepC5 had no effect on transmission. F, A
peptide derived from a region reported to interact with the hydrophobic core of the phospho-
lipid bilayer (s-TID3N) enhanced synaptic transmission.
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produced by s-pepA was not attributable to some nonspecific
property of the peptide, such as its charge.
Similarly, several peptides derived from the conserved do-
main C of synapsins reversibly inhibited release (Table 1). One of
these peptides (s-pepC5) profoundly and reversibly inhibited
synaptic transmission (Fig. 1D), whereas a control scrambled
peptide (scrambled s-pepC5) was without effect (Fig. 1E, Table
2). Finally, a peptide derived from the conserved C-terminal re-
gion of domain E fully and reversibly inhibited release, as re-
ported previously for a longer peptide derived from this region
(Table 1) (Hilfiker et al., 1998).
In contrast, peptides derived from less-conserved regions of
synapsin were relatively ineffective. For example, a peptide from
domain B only slightly inhibited synaptic transmission, whereas
peptides from domain V and from the variable nonconserved
N-terminal part of domain E had no effect (Table 1). Peptides
derived from sequences homologous to those reported to confer
calmodulin binding to rat synapsins in vitro (Hayes et al., 1991;
Nicol et al., 1997) reversibly inhibited transmission (s-CaM1 and
s-CaM2, Table 1), with the peptide derived from the region re-
ported to constitute a high-affinity calmodulin binding site
(Nicol et al., 1997)more potent than the peptide derived from the
second calmodulin-binding region. Because these calmodulin-
binding peptides may act as general calmodulin sinks, depleting
cellular levels of calmodulin necessary for exocytosis (Chamber-
lain et al., 1995; Chen et al., 1999; Quetglas et al., 2002) rather
than, or in addition to, interfering with synapsin-calmodulin in-
teractions in vivo, they were not investigated further. A peptide
(s-TID3N) encompassing a region of synapsins that appears to
interact with the hydrophobic core of the phospholipid bilayer
(Cheetham et al., 2001) had the unusual property of enhancing
synaptic transmission evoked by presynaptic action potentials
(Fig. 1F, Table 1). Because of possible nonspecific effects of this
peptide on lipid bilayer structure, this reagent was not studied
further.
In summary, these observations show that reagents (s-pepA,
s-pepC5, and s-pepE) from the three evolutionarily conserved
domains (A, C, and E) of squid synapsins specifically interfere
with neurotransmitter release. These results indicate that do-
mains A, C, and E may undergo interactions with binding part-
ners that are important for neurotransmitter release. The other
domains (B and V)may serve roles that do
not involve protein–protein interactions;
these domains may be structural or may
otherwise contribute to the function of
squid synapsins. The remainder of our
study focused on the functions of domains
A, C, and E, using the active peptides from
these domains.
Domain A peptide inhibits
neurotransmitter release in a
phosphorylation-dependent manner
s-pepA contains short sequences defining
a consensus phosphorylation site for PKA
and CaMKI. Domain A of vertebrate syn-
apsins is phosphorylated at this site (site 1)
by both kinases in vitro and in vivo (Hutt-
ner and Greengard, 1979; Czernik et al.,
1987). To test whether the squid domain A
peptide was phosphorylated by PKA and
CaMKI, we measured phosphorylation of
s-pepA in vitro. The kinetic parametersKm
(the apparent affinity for substrate) and kcat (the turnover num-
ber) were determined from linear regression analysis of
Lineweaver-Burk transformations that described the initial rates
of phosphorylation as a function of peptide concentration.
s-pepA was an excellent substrate for PKA phosphorylation (Km
of 22.3  8 M; kcat of 0.97  0.35 s
1; n  8) and CaMKI
phosphorylation (Km of 103 14.4M; kcat of 4.3 0.6 s
1; n
4), suggesting that full-length squid synapsins may be substrates
for phosphorylation by PKA and CaMKI as well.
To address whether the inhibitory action of s-pepA was de-
pendent on its phosphorylation state, we tested the effects of
chemically phosphorylated s-pepA (phospho-s-pepA). This pep-
tide was not capable of undergoing additional phosphorylation
by either PKAorCaMKI, indicating the effectiveness of the chem-
ical phosphorylation (Fig. 2A). No change in neurotransmitter re-
lease was detected, even during prolonged injections of phospho-
s-pepA (Fig. 2B, Table 2), indicating that s-pepA inhibited neuro-
transmitter release in a sequence- and phosphorylation-dependent
manner.
On the basis of primary sequence homology, domain A en-
compasses the N-terminal 28 residues of vertebrate synapsins. In
invertebrates, sequence identity is restricted to a rather short re-
gion surrounding phosphorylation site 1 (Hilfiker et al., 1998).
Indeed, a shorter version of s-pepA consisting of 11 amino acids
encompassing the consensus phosphorylation site (short s-pepA)
effectively and reversibly inhibited neurotransmitter release
evoked by presynaptic action potentials (Fig. 2B, Table 2), sug-
gesting that the functionally active region of domain A resides in
a short stretch of residues that includes phosphorylation site 1.
The phosphorylation-dependent inhibition of neurotrans-
mitter release mediated by s-pepA may be attributable to at least
two different mechanisms. Domain A of endogenous squid syn-
apsins may interact with a binding partner in a phosphorylation-
sensitive manner, which would cause this interaction to be dis-
rupted by s-pepA but not by the phosphorylated or scrambled
versions of this peptide. Alternatively, s-pepA might inhibit
transmitter release indirectly by decreasing the basal activity of
PKA, which is important for exocytosis at the squid giant synapse
(Hilfiker et al., 2001). In this case, s-pepA could inhibit exocytosis
by competing with endogenous PKA (and/or CaMKI) substrates
and alter their state of phosphorylation. To distinguish between
Table 2. Structural requirements for peptide inhibition of synaptic transmission
Peptide Sequence Concentration (mM)
Number of
injections
Amplitude
inhibition (%)
s-pepA VGFLKRRFSSGDLQGELRDAQE 20 10 75 6
2
Phospho-s-pepA VGFLKRRFSSGDLQGELRDAQE 20 4 0
Switched s-pepA VGFLKRRFGDSSLQGELRDAQE 20 4 57 12
Short s-pepA FLKRRFSSGDL 20 3 66 17
Short switched s-pepA FLKRRFGDSSL 20 2 83 10
Scrambled s-pepA VLERFRDQGSGSQLGDFARKLE 20 3 0
s-CaM1 TDWSKYFRGKKIFGDWDLRVE-amide 10 3 83 13
s-pepC2 PKFPVVVKIGHAHSGMGKVKVD-amide 10 6 33 13
s-pepC5 AFLRKSISGNWKANTGSAMLEQI-amide 10 14 80 5
Scrambled s-pepC5 SKWAEAINLSGLFTMKGINQRAS-amide 10 6 7 5
*
Mutant s-pepC5 AFLRKSISGNWQANTGSAMLEQI-amide 10 3 14 8
s-CaM2 VQKIGNNYKAFLRKSISG-amide 10 3 75 11
s-TID3N GKVKVDHHHAFQDIASVVAVTKS-amide 10 7 19 2
Peptideswere dissolved to the indicated concentrations in peptide injection buffer. EPSPsweremeasured before and at the peak of inhibition of the indicated
peptides. Data aremeans SEM. The consensus sequences for phosphorylation are underlined. The phosphorylated residue in phospho-s-pepA is indicated
with an arrow. Residues that are switched around are drawn in bold, andmutation of a crucial K residuemutated toQ is indicatedwith an asterisk. s-, Peptides
derived from squid synapsin sequences.
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these two possibilities, we designed a peptide that would serve as
neither a kinase substrate nor a kinase inhibitor. This was done by
altering the location of the phosphorylatable serine residue(s),
specifically by shifting the order of residues 9 and 10 with that of
residues 11 and 12 (Table 2, switched s-pepA). This peptide was
not phosphorylated by either PKAorCaMKI (Fig. 2A). It also did
not inhibit the phosphorylation of s-pepA by either PKA or
CaMKI, even if added in a 100-fold molar excess (Fig. 2C).
Although the peptide did not interact with the kinases, it did
cause a robust and reversible inhibition of transmitter release
(Fig. 2D, Table 2), as did a shorter version of this peptide (short
switched s-pepA) (Fig. 2D, Table 2). Thus, we conclude that
s-pepA and short s-pepA exert their effects not by altering basal
kinase activities but by interfering with the phosphorylation-
sensitive binding of domain A to a binding partner. This binding
interaction apparently is mediated by six N-terminal residues
that overlap with the consensus phosphorylation site.
Mechanism of domain A peptide action
Nearly all known perturbations of synapsin function, including
injection of a peptide from domain E, speed up the rate of syn-
aptic depression (Pieribone et al., 1995; Rosahl et al., 1995; Hil-
fiker et al., 1998;Humeau et al., 2001). Because the rate of depres-
sion is thought to reflect a dynamic equilibrium between the
readily releasable and reserve pools of synaptic vesicles, this ac-
celeration of depression is taken as an indication that the size of
the reserve pool is reduced when synapsin is impaired (Pieribone
et al., 1995; Rosahl et al., 1995;Hilfiker et al., 1998;Humeau et al.,
2001). To examine the contribution of domain A to this role of
synapsin, synaptic depressionwas elicited by trains of presynaptic
action potentials before and while reducing synaptic transmis-
sion by either injection of s-pepA (Fig. 3A) or lowering external
calcium concentration (Swandulla et al., 1991). During these
trains of synaptic activity, the amount of transmitter release per
presynaptic action potential declined with an exponential time
course (Fig. 3B). As expected, reducing synaptic transmission by
lowering external calcium concentration caused depression to
develop more slowly (Fig. 3B), with the time constant of depres-
sion inversely dependent on the initial level of transmitter release
(Fig. 3C). Surprisingly, s-pepA had no effect on synaptic depres-
sion at a given level of release (Fig. 3B,C). This provides an indi-
cation that the peptide is not affecting the reserve pool of synaptic
vesicles.
To further consider the possible effects of s-pepA on vesicle
pool size, we used electron microscopy to examine the effect of
this peptide on presynaptic ultrastructure. During the injection
of s-pepA, synaptic transmission was monitored, and the termi-
nals were fixed after the peptide had inhibited EPSP slope by
85% to ensure anymaximal structural effect. Control terminals
were treated similarly, except that they were injected with a sim-
ilar amount of scrambled peptide that did not inhibit synaptic
transmission. The ultrastructure of terminals injected with
s-pepA appeared identical to terminals injectedwith control pep-
tide (Fig. 4A,B).We looked formore subtle ultrastructural effects
by measuring the distribution of synaptic vesicles in the vicinity
of the active zone (Hess et al., 1993). s-pepA affected neither the
number of synaptic vesicles (Fig. 4C) nor their spatial distribu-
tion within the presynaptic terminal (Fig. 4D). This lack of
change in vesicle trafficking or number indicates that domain A
does not appear to regulate the reserve pool of synaptic vesicles.
Interfering with synapsins has been reported to slow the ki-
netics of neurotransmitter release (Hilfiker et al., 1998; Humeau
et al., 2001). To study whether s-pepA affected neurotransmitter
Figure 2. s-pepA inhibits neurotransmitter release in a phosphorylation-dependent man-
ner. A, An in vitro peptide phosphorylation experiment. The indicated peptides were subjected
to phosphorylation by either PKA (left) or CaMKI (right). The extent of phosphorylation of each
peptide (mean SEM;n3)was normalized to the amount of radioactivity incorporated into
s-pepA. Error bars are only shown when larger than the symbols. scr., Scrambled. B, phospho-
s-pepA had no effect on transmitter release. short s-pepA, encompassing the phosphorylation
site, reversibly inhibited transmitter release. C, Switched s-pepA does not act as a kinase inhib-
itor. Experiments were performed under initial rate conditions. The phosphorylation of s-pepA
by either PKA (left) or CaMKI (right) was not inhibited by up to 500M switched s-pepA. As a
positive control under the sameconditions, 50MPKI-amide (Walsh inhibitor) fully blocked the
phosphorylationof s-pepAbyPKA. Theextent of phosphorylationof s-pepA (meanSEM;n
5) was normalized to the amount of radioactivity incorporated into s-pepA in the absence of
switched s-pepA orWalsh inhibitor peptides.D, Injection of switched s-pepA (solid bar) revers-
ibly inhibited neurotransmitter release. Injection of short switched s-pepA (solid bar) reversibly
inhibited neurotransmitter release.
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release kinetics, we used voltage clamping to measure EPSCs
evoked by presynaptic action potentials. s-pepA did not slow the
kinetics of EPSCs, with EPSC onset being 97 2%of control and
EPSC decay being 103 4% of control after injection of peptide
(n 3) (Fig. 4E,F). In summary, it appears that domain A par-
ticipates in a phosphorylation-sensitive interaction that does not
alter the reserve pool of synaptic vesicles or the kinetics of trans-
mitter release.
Domain C peptide inhibits neurotransmitter release
We explored the function of domain C by further characterizing
the physiological effects of s-pepC5. Synapsin domain C shows
striking structural similarity tomembers of a family of ATP-using
enzymes (Esser et al., 1998; Brautigam et al., 2004). Members of
this ATP-grasp family contain a flexible, catalytically essential
loop (“multifunctional loop”) that is unstructured in the unli-
ganded enzyme but assumes a fixed conformation during sub-
strate binding. Such a multifunctional loop has also been found
in the crystal structure of domain C of rat synapsin, and the
amino acid sequence of s-pepC5 (equivalent to residues 325–347
in rat synapsin I) encompasses all residues involved in forming
the multifunctional loop exposed on the surface of the protein
(equivalent to residues 330–343 of rat synapsin I). In addition, a
basic residue in this loop of domainCof synapsin has been shown
to be important for ATP binding (Brau-
tigam et al., 2004). To test the functional
importance of this residue, we generated a
mutant version of s-pepC5 (mutant
s-pepC5) with a glutamine residue replac-
ing the positively charged lysine residue
within the loop. Injecting this point-
mutated peptide inhibited release by an
average of 14  8% (n  3), whereas in-
jecting comparable amounts of active
s-pepC5 inhibited release by an average of
80 5% (n 14) (Fig. 5A, Table 2). These
data further confirm that the effects of
s-pepC5 were highly sequence specific.
Domain C regulates the reserve pool
of vesicles
To examine the contribution of domain C
to the maintenance of the reserve pool of
synaptic vesicles, synaptic depression was
elicited by trains of presynaptic action po-
tentials as described above. EPSPs of com-
parable size depressed much more rapidly
after s-pepC5 injection thanwhen lowered
external calciumwas used to reduce trans-
mitter release (Fig. 5B). This acceleration
of depression indicates that disruption of
synapsin function by s-pepC5 injection re-
duces a pool of vesicles available for
release.
We also used electron microscopy to
examine the effect of s-pepC5 on presyn-
aptic ultrastructure. s-pepC5-injected ter-
minals exhibited a decrease in the total
number of vesicles within the active zone
compared with terminals injected with a
scrambled control peptide (Fig. 5C,D).
The total number of vesicles within 500
nm of the plasma membrane was reduced
by 25% ( p 0.001) (Fig. 5E). A detailed morphometric analysis
indicated that s-pepC5 preferentially reduced the size of the dis-
tal, reserve pool of vesicles clustered in the vicinity of the active
zone (Pieribone et al., 1995) but did not alter the number of
proximal, docked vesicles (Fig. 5F). These data are consistent
with the observation that s-pepC5 injection accelerates synaptic
depression and indicate that the size of the reserve pool of vesicles
depends on a function of synapsin that involves domain C.
Domain C peptide regulates a post-docking step of the
release process
Besides reducing reserve pool size, s-pepC5 also seemed to affect
neurotransmitter release more directly. First, the number of
docked vesicles (those within 50 nm of the active zone), which is
thought to include or represent a readily releasable pool of vesi-
cles (Parsons et al., 1995; Schikorski and Stevens, 1997), was un-
changed during s-pepC5 injection (94% of control; p 0.5) (Fig.
5F), whereas neurotransmitter release was inhibited (Fig. 1D).
This indicates that s-pepC5 inhibits the ability of docked synaptic
vesicles to fuse with the plasma membrane.
Consistent with the reduction of EPSP amplitude and rate of
rise (Fig. 1D), injection of a submaximal concentration of
s-pepC5 reduced the peak amplitude of EPSCs by 61 6% (n
3) (Fig. 6A). However, s-pepC5 also slowed both the onset (by
Figure3. s-pepAhas no effect on synaptic depression.A, Trains of stimuli (arrows)were appliedwhile injecting s-pepA.B, The
time course of depressionduring trainswas determined from the first 75 responseswhen transmissionwas normal (open squares;
n 8), reduced to 50%by lowered extracellular calcium (filled triangles; n 3), or reduced to 50%by injection of s-pepA (open
inverted triangles; n 6). The traces shown representmean postsynaptic responses, whichwere normalized to the last response
before the train. C, Comparison of effects of lowered external calcium and s-pepA injection on the time constants for depression
calculated from data of the type illustrated in B. Synaptic depression was elicited at various time points during inhibition of
neurotransmitter release by either lowering extracellular calcium (filled triangles; n 3) or injection of s-pepA (open inverted
triangles; n 4). Values obtained within a 5% difference in synaptic transmission were binned. The time constants are
means SEM of at least two and maximally 12 individual traces. Error bars (indicating SEM) are only visualized when
larger than the symbol size.
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19 1%) and the decay (by 26 9%) of the EPSC (n 3) (Fig.
6B). These kinetic effects of s-pepC5 were reversible and de-
pended on the amount of peptide injected into the presynaptic
terminal (data not shown). Because s-pepC5was injected directly
into the presynaptic terminal, this peptide seemed to alter EPSC
kinetics by changing the time course of transmitter release rather
than by modifying postsynaptic glutamate receptors or trans-
porters. These changes in kinetics are not attributable to the re-
ductions in transmitter release or vesicle pool size per se, because
many treatments that reduce neurotransmitter release (Bommert
et al., 1993; Hess et al., 1993; Hunt et al., 1994; DeBello et al.,
1995;O’Connor et al., 1997; Burns et al., 1998) or vesicle pool size
(Hess et al., 1993; DeBello et al., 1995; Burns et al., 1998) do not
slow EPSC time course (Schweizer et al., 1998). Together, these
data suggest that domain C of synapsins is not only required for
maintaining vesicle clusters at the active zone but also partici-
Figure4. s-pepAhasno effect onpresynaptic ultrastructure or on the kinetics of neurotrans-
mitter release. Electron micrographs of terminals injected with control (A) or active s-pepA (B)
are shown. Scale bars, 0.5m. C, Mean SEM number of synaptic vesicles within a 500 nm
shell starting from the plasma membrane of active zones (AZs) injected with control peptide
(control; white bar) or s-pepA (black bar). D, Distribution of synaptic vesicles (50 nm shell) per
active zone (AZ) after injection of scrambled peptide (white bars; n 187 active zones, 2
terminals) or s-pepA (black bars; n 194 active zones, 2 terminals). *p 0.01 (Student’s t
test). E, Presynaptic potentials (Vpre) and postsynaptic currents (EPSC) before (black line) and
during (gray line) injection of s-pepA. F, EPSCs from E scaled to identical peak amplitudes show
no change in EPSC time coursewith s-pepA. Results shown are representative of three indepen-
dent experiments.
Figure 5. s-pepC5 enhances synaptic depression and decreases the number of synaptic ves-
icles. A, Mutant s-pepC5 was much less effective in inhibiting release compared with s-pepC5
(right), although comparable amounts of eachpeptidewere sequentially injected into the same
synapse. B, Time constants for depression were calculated as described in the legend to Figure
4. Synaptic depressionwas elicited at various time points during inhibition of neurotransmitter
release by either lowering extracellular calcium (filled triangles; n 3) or injecting s-pepC5
(open circles; n 10). Values obtained within a 5% difference in synaptic transmission were
binned. The time constants are means SEM of at least two and maximally 15 individual
traces. Error bars (indicating SEM) are only visualizedwhen larger than the symbol size. Electron
micrographs of terminals injectedwith scrambled s-pepC5 (C) and s-pepC5 (D) are shown. Scale
bars, 0.5m. E, Mean SEM number of synaptic vesicles within a 500 nm shell starting from
the plasma membrane of active zones (AZs) injected with scrambled s-pepC5 (control; white
bar) or s-pepC5 (black bar). F, Distribution of synaptic vesicles (50 nm shell) per active zone (AZ)
after injection of scrambled s-pepC5 (white bars; n 187 active zones, 2 terminals) or s-pepC5
(black bars; n 188 active zones, 2 terminals). *p 0.01; **p 0.001 (Student’s t test).
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pates more directly in reactions that determine the kinetics of
neurotransmitter release.
Domain C peptide does not affect synapsin binding to
synaptic vesicles
The changes in synaptic transmission and presynaptic ultrastruc-
ture produced by the domainCpeptide s-pepC5were identical to
those produced by injecting s-pepE, a peptide from domain E
(Hilfiker et al., 1998). The similarity in the actions of structurally
unrelated peptides from two different domains substantiates that
these effects are attributable to specific impairments of synapsin
function and, thus, that synapsins are required to both regulate a
reserve pool of synaptic vesicles and modulate a second step that
controls the kinetics of neurotransmitter release. Having two dis-
tinct and specific peptide reagents that elicit identical presynaptic
phenotypes, we next used in vitro binding assays to determine
how these peptides interfered with the biochemical functions of
synapsins. We compared the actions of these two peptides with
each other and with the actions of s-pepA, which also affects
transmitter release but has physiological and ultrastructural ef-
fects quite different from those of the other two peptides.
The best studied interactions of synapsins are binding to syn-
aptic vesicles and to actin (Schiebler et al., 1986; Ba¨hler and
Greengard, 1987; Ba¨hler et al., 1989; Benfenati et al., 1989a,b,
1992a,b, 1993a,b; Thiel et al., 1990; Chilcote et al., 1994; Ceccaldi
et al., 1995; Hosaka et al., 1999; Hurley et al., 2004). We deter-
minedwhether the domainC andE peptides prevented synapsins
from binding to synaptic vesicles. The binding of exogenous syn-
apsin I to highly purified, synapsin-depleted synaptic vesicles
(Huttner et al., 1983) was not significantly affected by the pres-
ence of either scrambled control peptides or by active domain C
and E peptides, even at concentrations as high as 5 mM (Fig. 7).
The binding of synapsin I to vesicles also was not affected when
corresponding concentrations of the two active peptides were
added simultaneously (data not shown). Thus, it is unlikely that
the domain C and E peptides inhibit transmitter release by inter-
fering directly with the binding of synapsins to synaptic vesicles.
Domain C peptide interferes with synapsin–actin interactions
Synapsins bind to F-actin, an interaction that has been proposed
to play a key role in the synapsin-mediated regulation of synaptic
vesicle trafficking (Greengard et al., 1993). In addition, synapsins
bundle preformed actin filaments (Ba¨hler and Greengard, 1987;
Petrucci and Morrow, 1987; Chilcote et al., 1994) and enhance
the polymerization of actin monomers into filaments (Fesce et
al., 1992; Valtorta et al., 1992), suggesting that synapsinsmay also
regulate the dynamics of actin-based networks within presynap-
tic terminals (Benfenati et al., 1992a).
We studied the effects of pepC5 on binding of synapsin to
Figure 7. s-pepC5 has no effect on synapsin–synaptic vesicle interactions. Purified synapsin
Iwas incubatedwith rat-derived, synapsin-depleted synaptic vesicles (SSV) in the absence ()
or presence (; 1 or 5mM final concentration) of rat synapsin I pepC5 (C), rat synapsin I pepE (E),
or scrambled (scr) versions thereof. Synaptic vesicles were recovered by high-speed centrifuga-
tion, and the amounts of synapsin I and synaptophysin (data not shown) in the pellets were
analyzed by immunoblotting.
Figure 8. s-pepC5 interferes with synapsin–F-actin interactions. A, Purified synapsin I was
incubatedwith F-actin in theabsence () or presence () of variousmillimolar concentrations
of either rat synapsin I pepC (C) or scrambled pepC (scrC), followed by high-speed centrifuga-
tion. Samples of F-actin pellets, normalized for the F-actin content, were subjected to immu-
noblotting for synapsin and actin.B, Dose-dependent inhibition of synapsin I binding to F-actin
by rat synapsin I pepC (pepC5), scrambled rat synapsin I pepC (scrambled pepC5), rat synapsin I
pepE (pepEI), scrambled rat synapsin I pepE (scrambled pepE), or rat synapsin II pepE (pepEII)
(Hilfiker et al., 1998). The amounts of immunoreactive synapsin I bound to F-actin in the ab-
sence or presence of various concentrations of the peptides and normalized for equal F-actin
concentration are expressed as the percentage of the binding observed in the absence of pep-
tides (means SEM; n 6). *p 0.01 (Dunnett’s test).
Figure 6. s-pepC5 slows the kinetics of neurotransmitter release. A, Presynaptic potentials
(Vpre) and postsynaptic currents (EPSC) before (black line) and during (gray line) injection of
s-pepC5. B, EPSCs from A scaled to identical peak amplitudes show the slowing of EPSC time
course with s-pepC5. Results shown are representative of three independent experiments.
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F-actin by incubating purified synapsin I with preformed actin
filaments. Bindingwas then assessed bymeasuring the amount of
synapsins that copelleted with F-actin after high-speed centrifu-
gation. pepC5 caused a concentration-dependent inhibition of
synapsin I binding to actin filaments, whereas scrambled pepC5
had little effect (Fig. 8A,B). Approximately 80%of synapsin I was
displaced by 5 mM pepC5 (Fig. 8B), a concentration that should
fully inhibit neurotransmitter release. Likewise, rat synapsin I
pepE caused a specific and concentration-dependent inhibition
of synapsin I binding to actin filaments (Fig. 8B). In agreement
with their functional and sequence similarity (Hilfiker et al.,
1998), rat synapsin I pepE, rat synapsin II pepE, and squid syn-
apsin pepE all inhibited the binding of synapsin to F-actin in a
concentration-dependent manner, whereas
their respective scrambled counterparts had
little effect (Fig. 8B and data not shown).
Furthermore, both pepC5 and pepE specifi-
cally interfered with the ability of synapsin I
tobundleF-actin filaments (Fig. 9A anddata
not shown) and to enhance the polymeriza-
tion of G-actin into filaments (Fig. 9B and
data not shown). In summary, both domain
C and E peptides specifically interfered with
the binding of synapsin I to actin filaments.
This indicates a possible molecular mecha-
nism for the inhibition of neurotransmitter
release by these peptides.
In contrast, even high concentrations
of s-pepA (up to 5 mM) did not affect the
binding of exogenous synapsin I to
synapsin-depleted synaptic vesicles (Fig.
10A) and had no effect on synapsin–F-
actin interactions (Fig. 10B,C and data not
shown). This provides another indication that s-pepA inhibits
neurotransmitter release through amechanismdistinct from that
of s-pepC5 or s-pepE.
Discussion
We used the squid giant synapse to analyze the function of vari-
ous domains of synapsins. Presynaptic injection of peptides en-
compassing all domains of synapsins revealed that the three evo-
lutionarily conserved domains (A, C, and E) play distinct and
overlapping roles in the synapsin-dependent regulation of neu-
rotransmitter release.
Function of synapsin domain A
We found that a peptide derived from domain A of synapsins
inhibited neurotransmitter release in a phosphorylation-
dependent manner without effects on vesicle pool size or neuro-
transmitter release kinetics. The molecular mechanism involved
in the inhibitory effect is unclear, because this peptide had no
effect on either synapsin–actin or synapsin–vesicle interactions.
Domain A is known to interact with phospholipids, and this in-
teraction is neutralized by phosphorylation (Hosaka et al., 1999);
this may underlie the effect of the domain A peptide on transmit-
ter release. Interfering with synapsin–lipid interactions may re-
sult in a subtle decrease in the affinity of binding of synapsins to
synaptic vesicles, which might not be detectable in biochemical
experiments yet still affect transmitter release evoked by single
action potentials. Additional work is necessary to clarify the
mechanism of domain A peptide action.
Synapsin domains C and Emaintain a reserve pool of vesicles
Numerous studies indicate that synapsins regulate the size of a
reserve pool of vesicles away from the plasmamembrane (Li et al.,
1995; Pieribone et al., 1995; Takei et al., 1995; Hilfiker et al., 1998;
Humeau et al., 2001). This ultrastructural change is paralleled by
an increase in synaptic depression observed during high-
frequency stimulation (Pieribone et al., 1995; Rosahl et al., 1995;
Hilfiker et al., 1998; Humeau et al., 2001), suggesting that the
synapsin-dependent reserve pool of vesicles away from the
plasma membrane is required to maintain release under these
conditions. Our results have implicated domains C and E in this
presynaptic function of synapsins. A peptide derived from the
largest, conserved domain C of synapsins inhibited neurotrans-
mitter release evoked by presynaptic action potentials, acceler-
ated synaptic depression elicited by high-frequency stimulation,
and depleted a pool of synaptic vesicles located away from the
plasma membrane. The physiological and ultrastructural
changes mediated by this peptide were identical to those seen
with a peptide derived from domain E, which is the C-terminal
part of squid synapsins and mammalian A-type synapsin iso-
forms (Hilfiker et al., 1998). Thus, it appears that domains C and
E participate in the maintenance of the reserve pool of synaptic
vesicles by synapsins.
Our observations that domain C and E peptides displayed
identical effects on presynaptic physiology and ultrastructure
suggest that these two peptides interfere with the same interac-
tion of synapsins. In fact, both of these peptides selectively and
specifically compete for the binding of synapsin to F-actin. This
indicates that both domains either directly or indirectly mediate
the binding of synapsins to presynaptic actin filaments. In agree-
Figure 9. Peptide effect on synapsin-mediated F-actin bundling and G-actin polymeriza-
tion. Purified synapsin I was incubatedwith either F-actin (A) or G-actin (B) in the absence ()
or presence () of 1 mM rat synapsin I pepE (El), rat synapsin II pepE (EII), or scrambled rat
synapsin I pepE (Escr) (Hilfiker et al., 1998). F-actin bundling (A) was analyzed by low-speed
centrifugation to selectively pellet bundles of filaments. G-actin polymerization (B) was as-
sessed by high-speed centrifugation to pellet actin filaments. Pellet fractions are shown after
SDS-PAGE and Coomassie blue staining.
Figure 10. s-pepA does not interferewith synapsin–actin or synapsin–synaptic vesicle interactions.A, Purified synapsin Iwas
incubated with rat-derived, synapsin-depleted synaptic vesicles (SSV) in the absence or presence (1 or 5 mM final concentration)
of rat synapsin I pepA (A) or a scrambled (scr) version thereof. Synaptic vesicleswere recovered by high-speed centrifugation, and
the amounts of synapsin I and synaptophysin (data not shown) in the pellets were analyzed by immunoblotting. B, Purified
synapsin Iwas incubatedwith F-actin in the absence or presence of variousmillimolar concentrations of either rat synapsin I pepA
(A) or scrambled pepA (scrA), followed by high-speed centrifugation. Samples of F-actin pellets, normalized for F-actin content,
were subjected to immunoblotting for synapsinandactin.C, Absenceofdose-dependent inhibitionof synapsin I binding toF-actin
by s-pepA. The amounts of immunoreactive synapsin I bound to F-actin in the absence or presence of various concentrations of the
peptides and normalized for equal F-actin concentration are expressed as the percentage of the binding observed in the absence
of peptides (means SEM; n 6). *p 0.01 (Dunnett’s test).
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ment with this conclusion, domain mapping studies have shown
that a fragment corresponding to themiddle region of synapsin I,
encompassing the sequence of s-pepC5, binds to F-actin, whereas
a fragment corresponding to its C-terminal region was inactive
(Ba¨hler et al., 1989). The fragment corresponding to bothmiddle
and C-terminal regions exhibited actin binding and bundling
activities comparable with those of holosynapsin I. This suggests
that the C-terminal region, which contains domain E, may adopt
a different conformation in the presence of domain C (Ba¨hler et
al., 1989). Such intramolecular interactions of synapsin domains
have also been postulated to be important for targeting of syn-
apsins (Gitler et al., 2004a). The present correlation between the
effects of these peptides on transmitter release, vesicle localiza-
tion, and interactions with actin indicates that binding to presyn-
aptic actin filaments underlies the role of synapsins in regulating
the availability of synaptic vesicles for neurotransmitter release. It
is tempting to speculate that this arises from synapsin-dependent
tethering of synaptic vesicles to actin filaments adjacent to the
plasma membrane, as has been proposed previously (Greengard
et al., 1993).
The role of actin in the synaptic vesicle cycle is controversial
(Doussau and Augustine, 2000). Various studies have led to pro-
posals that actin has no presynaptic function (Job and Lagnado,
1998) or that actin plays negative (Wang et al., 1996; Bernstein et
al., 1998; Morales et al., 2000; Sankaranarayanan et al., 2003) or
positive (Kuromi and Kidokoro, 1998; Cole et al., 2000; Sakaba
andNeher, 2003) roles in synaptic vesiclemobilization. It has also
been proposed that actin is involved in other aspects of vesicle
recycling (Shupliakov et al., 2002). These discrepancies may be
attributable to the types and/or sizes of the synapses studied. For
example, disruption of actin depletes the presynaptic cluster of
vesicles at the giant lamprey synapse (Shupliakov et al., 2002) yet
has no effects on vesicle pool size at small hippocampal synapses
(Sankaranarayanan et al., 2003). Because the amount of free
space surrounding the vesicle cluster is small at hippocampal
synapses, dilution of vesicles may not occur after actin is dis-
rupted. In contrast, the large amount of free space surrounding
vesicle clusters could allow depletion of reserve pool vesicles after
disruption of the actin cytoskeleton at giant synapses (Shupliakov
et al., 2002).
Synapsin domains C and E regulate release kinetics
An additional action of synapsins, downstream of clustering the
reserve pool of vesicles, is indicated by observations that interfer-
ing with synapsins slows the kinetics of neurotransmitter release
(Hilfiker et al., 1998; Humeau et al., 2001). This has led to the
proposal that synapsins exhibit actions downstream of vesicle
docking that cause either a desynchronization of neurotransmit-
ter release or a change in the gating of fusion pores.
We found that a peptide fromdomainC slows release kinetics,
as does a domain E peptide (Hilfiker et al., 1998). Given that these
two domains are involved in maintaining vesicles in the reserve
pool, it is possible that the changes in release kinetics are a sec-
ondary consequence of depleting the reserve pool. Alternatively,
the kinetic changes could arise from a more direct effect of syn-
apsins on a membrane-associated pool of releasable vesicles, as
postulated previously. Although approximately half of synapsin
molecules dissociate from synaptic vesicles during synaptic activ-
ity (Sihra et al., 1989; Torri-Tarelli et al., 1992;Hosaka et al., 1999;
Chi et al., 2001, 2003), the remainder stays bound to vesicles close
to and/or attached to the membrane (Bloom et al., 2003). This
would allow synapsins to regulate the kinetics of transmitter re-
lease downstream of vesicle docking.
Because both domains C and E interact with actin, interfering
with their function might change release kinetics by interfering
with endogenous actin–synapsin interactions or could be down-
stream of their effects on synapsin–actin interactions. It is inter-
esting to note that a mutant version of s-pepC5, in which a basic
residue was mutated to a glutamine, only moderately inhibited
release compared with the active peptide. This basic residue has
been shown to be important for ATP binding of synapsin I (Brau-
tigam et al., 2004), and similar basic residues are implicated in
substrate binding in the surface-exposed multifunctional loop of
other members of the ATP-grasp family of enzymes that are
structurally related to synapsin domain C (Tanaka et al., 1992).
The effect of s-pepC5 on transmitter release is unlikely attribut-
able to its binding of ATP, because residues beyond those in the
peptide are important for stabilizing the bound state of ATP
(Brautigam et al., 2004). Furthermore, reducing ATP levels
within the presynaptic terminal would slow the synaptic delay
significantly (Adams et al., 1985), which we did not observe after
microinjection of s-pepC5. However, the kinetic effects of the
domainC andEpeptides could arise from interferencewith some
enzymatic function of synapsins.
Comparison with genetic knock-out studies
Knocking out mouse genes for synapsins II or III affects synaptic
depression (Rosahl et al., 1995; Feng et al., 2002; Gitler et al.,
2004b), consistent with the physiological actions of peptides that
interfere with domains C or E. Perturbing domains A, C, or E also
affects basal transmitter release, which parallels the decline in
basal release of GABA reported in mouse hippocampal neurons
inwhich all three synapsin genes have been knocked out (Gitler et
al., 2004b). Deletion of all three synapsin genes does not affect
basal release of glutamate (Gitler et al., 2004b), which contrasts
with the effects of synapsin peptides at the glutamatergic squid
synapse. Why the effects of disturbing synapsin function depend
on the type of synapse is not yet clear. One variable may be the
rate of spontaneous transmitter release. Disturbing synapsin
function in synapses with high rates of spontaneous neurotrans-
mitter release, such as the squid giant synapse, may have more
effect on basal release because the high spontaneous release may
require ongoing traffic from the reserve pool of synaptic vesicles.
In conclusion, our data indicate that synapsins regulate both
vesicle pool size and transmitter release kinetics at the squid giant
synapse. This regulation depends on domains C and E of syn-
apsins and may involve an actin-mediated tethering of synapsins
close to the plasmamembrane at the active zone. Domain A has a
different function that affects transmitter release via a mecha-
nism that remains to be determined. Thus, different domains of
synapsinsmake different contributions to the actions of thismul-
tifunctional regulator of the presynaptic terminal.
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